Skip to content

Testing the efficacy of lens with highly aspherical lenslet for myopia control.

Myopia control efficacy of Spectacle lenses with Highly aspherical lenslets (HAL) in high myopia. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088239
Enrollment
50
Registered
2025-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: highly Aspherical lenslets: 3 month, 6 months and 12 months Control Intervention1: High Myopic children with single vision spectacles: 3 month, 6 months and 12 months

Sponsors

Essilor R & D Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 6 to 14 years inclusive at time of enrolment 2.Interested in wearing spectacles for 5 days per week and 6 hours in a day 3.Best-corrected high contrast visual acuity based on manifest refraction of 0.18 logMAR 4.spherical equivalent-6.00 D to -11 5. astigmatic component 0 DC to -3.0DC 6.Spherical equivalent anisometropia less than or equal to 2.50 D

Exclusion criteria

Exclusion criteria: 1.Current or prior use of ANY form of myopia control strategy 2.Participant born earlier than 30 weeks or weighed less than 1500 gm at birth 3.Any ocular, systemic, or neuro-developmental conditions that may influence refractive error 4.Manifest strabismus (tropia) 5.Any known ocular inflammation or infection

Design outcomes

Primary

MeasureTime frame
Change in axial lengthTimepoint: 3 Months, 6 months and 12 months

Secondary

MeasureTime frame
change in spherical equivalent refractive errorTimepoint: Base line, 3,6, 12 months

Countries

India

Contacts

Public ContactManisha Paudel

L V Prasad Eye Institute

manishapaudel32@gmail.com6281845707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026